These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29895412)

  • 21. Stress ulcer prophylaxis in non-critically ill patients: a prospective evaluation of current practice in a general surgery department.
    Bez C; Perrottet N; Zingg T; Leung Ki EL; Demartines N; Pannatier A
    J Eval Clin Pract; 2013 Apr; 19(2):374-8. PubMed ID: 22420909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries.
    Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; McArthur C; Cook D; Nielsen N; Pelosi P; Keus F; Guttormsen AB; Moller AD; Møller MH;
    Acta Anaesthesiol Scand; 2015 May; 59(5):576-85. PubMed ID: 25880349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of clinical pharmacy services on stress ulcer prophylaxis prescribing and related cost in patients with renal insufficiency.
    Mousavi M; Dashti-Khavidaki S; Khalili H; Farshchi A; Gatmiri M
    Int J Pharm Pract; 2013 Aug; 21(4):263-9. PubMed ID: 23418812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and factors associated with inappropriate continuation of stress ulcer prophylaxis at discharge.
    Chinnappan J; Al-Handola R; Joseph NM; Ogbon E; McDonald PJ
    BMJ Open Qual; 2024 May; 13(2):. PubMed ID: 38729753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stress ulcer prophylaxis in critical illness: a Canadian survey.
    Shears M; Alhazzani W; Marshall JC; Muscedere J; Hall R; English SW; Dodek PM; Lauzier F; Kanji S; Duffett M; Barletta J; Alshahrani M; Arabi Y; Deane A; Cook DJ
    Can J Anaesth; 2016 Jun; 63(6):718-24. PubMed ID: 26911559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol.
    Young PJ; Bagshaw SM; Forbes A; Nichol A; Wright SE; Bellomo R; Bailey MJ; Beasley RW; Eastwood GM; Festa M; Gattas D; van Haren F; Litton E; Mouncey PR; Navarra L; Pilcher D; Mackle DM; McArthur CJ; McGuinness SP; Saxena MK; Webb S; Rowan KM;
    Crit Care Resusc; 2018 Sep; 20(3):182-189. PubMed ID: 30153780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What's new with stress ulcer prophylaxis in the ICU?
    Marker S; Krag M; Møller MH
    Intensive Care Med; 2017 Aug; 43(8):1132-1134. PubMed ID: 28238056
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacological interventions for stress ulcer prophylaxis in critically ill patients: a mixed treatment comparison network meta-analysis and a recursive cumulative meta-analysis.
    Sridharan K; Sivaramakrishnan G; Gnanaraj J
    Expert Opin Pharmacother; 2018 Feb; 19(2):151-158. PubMed ID: 29271262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and cost of stress ulcer prophylaxis after discharge from the intensive care unit: a retrospective study.
    Tan B; Norman R; Litton E; Heath C; Hawkins DJ; Krishnamurthy R; Sonawane R; Anstey MH
    Crit Care Resusc; 2016 Dec; 18(4):270-274. PubMed ID: 27903209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern of intravenous proton pump inhibitors use in ICU and Non-ICU setting: a prospective observational study.
    Alsultan MS; Mayet AY; Malhani AA; Alshaikh MK
    Saudi J Gastroenterol; 2010; 16(4):275-9. PubMed ID: 20871193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Benefits and risks of stress ulcer prevention with proton pump inhibitors for critical patients: an observational cohort study with 1 972 patients].
    Sun J; Wang B; Cao P; Zhu H; Lu K; Geng P; Tan D
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):539-544. PubMed ID: 31198136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequences.
    Barletta JF; Sclar DA
    Pharmacoeconomics; 2014 Jan; 32(1):5-13. PubMed ID: 24271943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients. A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.
    Krag M; Perner A; Wetterslev J; Wise MP; Hylander Møller M
    Intensive Care Med; 2014 Jan; 40(1):11-22. PubMed ID: 24141808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stress Ulcer Prophylaxis in Cardiac Surgery: A Retrospective Cohort Study to Analyze the Effects of SUP Cessation.
    Mekhail A; Young P; Mekhail AM; Tinawi G; Haran C; Clayton N; Galvin S
    J Intensive Care Med; 2023 Oct; 38(10):917-921. PubMed ID: 37093762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opinions and practice of stress ulcer prophylaxis in Australian and New Zealand intensive care units.
    Eastwood GM; Litton E; Bellomo R; Bailey MJ; Festa M; Beasley RW; Young PJ
    Crit Care Resusc; 2014 Sep; 16(3):170-4. PubMed ID: 25161018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stress ulcer prophylaxis for critically ill children: routine use needs to be re-examined.
    Abu El-Ella SS; El-Mekkawy MS; Mohamed Selim A
    An Pediatr (Engl Ed); 2022 May; 96(5):402-409. PubMed ID: 35701033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of stress ulcer prophylaxis in adult ICU patients receiving renal replacement therapy (Sup-Icu RENal, SIREN): Study protocol for a pre-planned observational study.
    Schefold JC; Perner A; Lange T; Wetterslev J; Wise MP; Borthwick M; Bendel S; Keus F; Guttormsen AB; Marker S; Krag M; Møller MH;
    Trials; 2018 Jan; 19(1):26. PubMed ID: 29321041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-Effectiveness of Histamine
    Hammond DA; Kathe N; Shah A; Martin BC
    Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stress ulcer prophylaxis in the intensive care unit trial: detailed statistical analysis plan.
    Krag M; Perner A; Wetterslev J; Lange T; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Meyhoff TS; Marker S; Møller MH
    Acta Anaesthesiol Scand; 2017 Aug; 61(7):859-868. PubMed ID: 28608496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stress ulcer prophylaxis in children with status asthmaticus receiving systemic corticosteroids: a descriptive study assessing frequency of clinically important bleeding.
    Sochet AA; Son S; Ryan KS; Roddy M; Barrie E; Wilsey M; McKinley SD; Nakagawa TA
    J Asthma; 2020 Aug; 57(8):858-865. PubMed ID: 31046509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.